
Oncology Drugs Approved by the FDA in March 2025
The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for gastrointestinal and genitourinary cancers such as prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate …